These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33441564)

  • 21. Approaches and advances in the development of potential therapeutic targets and antiviral agents for the management of SARS-CoV-2 infection.
    Krishna G; Pillai VS; Veettil MV
    Eur J Pharmacol; 2020 Oct; 885():173450. PubMed ID: 32739174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene signatures and potential therapeutic targets of Middle East respiratory syndrome coronavirus (MERS-CoV)-infected human lung adenocarcinoma epithelial cells.
    Wu YH; Yeh IJ; Phan NN; Yen MC; Hung JH; Chiao CC; Chen CF; Sun Z; Hsu HP; Wang CY; Lai MD
    J Microbiol Immunol Infect; 2021 Oct; 54(5):845-857. PubMed ID: 34176764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential.
    Xu J; Shi PY; Li H; Zhou J
    ACS Infect Dis; 2020 May; 6(5):909-915. PubMed ID: 32125140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Roles of flavonoids against coronavirus infection.
    Russo M; Moccia S; Spagnuolo C; Tedesco I; Russo GL
    Chem Biol Interact; 2020 Sep; 328():109211. PubMed ID: 32735799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
    Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W
    Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural and Nature-Derived Products Targeting Human Coronaviruses.
    Vougogiannopoulou K; Corona A; Tramontano E; Alexis MN; Skaltsounis AL
    Molecules; 2021 Jan; 26(2):. PubMed ID: 33467029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Potential of Algal Biotechnology to Produce Antiviral Compounds and Biopharmaceuticals.
    Rosales-Mendoza S; García-Silva I; González-Ortega O; Sandoval-Vargas JM; Malla A; Vimolmangkang S
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32899754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sensitivity of SARS/MERS CoV to interferons and other drugs based on achievable serum concentrations in humans.
    Strayer DR; Dickey R; Carter WA
    Infect Disord Drug Targets; 2014; 14(1):37-43. PubMed ID: 25019238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. UBR5 Acts as an Antiviral Host Factor against MERS-CoV via Promoting Ubiquitination and Degradation of ORF4b.
    Zhou Y; Zheng R; Liu D; Liu S; Disoma C; Li S; Liao Y; Chen Z; Du A; Dong Z; Zhang Y; Liu P; Razzaq A; Chen D; Chen X; Zhong X; Liu S; Tao S; Liu Y; Xu L; Deng X; Li J; Jiang T; Zhao J; Li S; Xia Z
    J Virol; 2022 Sep; 96(17):e0074122. PubMed ID: 35980206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What are our pharmacotherapeutic options for MERS-CoV?
    Al-Tawfiq JA; Memish ZA
    Expert Rev Clin Pharmacol; 2014 May; 7(3):235-8. PubMed ID: 24580083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past.
    Shah VK; Firmal P; Alam A; Ganguly D; Chattopadhyay S
    Front Immunol; 2020; 11():1949. PubMed ID: 32849654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
    Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative transcriptome analysis of SARS-CoV, MERS-CoV, and SARS-CoV-2 to identify potential pathways for drug repurposing.
    Krishnamoorthy P; Raj AS; Roy S; Kumar NS; Kumar H
    Comput Biol Med; 2021 Jan; 128():104123. PubMed ID: 33260034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of Coronavirus Entry
    Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
    mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL
    Kumar V; Shin JS; Shie JJ; Ku KB; Kim C; Go YY; Huang KF; Kim M; Liang PH
    Antiviral Res; 2017 May; 141():101-106. PubMed ID: 28216367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting zoonotic viruses: Structure-based inhibition of the 3C-like protease from bat coronavirus HKU4--The likely reservoir host to the human coronavirus that causes Middle East Respiratory Syndrome (MERS).
    St John SE; Tomar S; Stauffer SR; Mesecar AD
    Bioorg Med Chem; 2015 Sep; 23(17):6036-48. PubMed ID: 26190463
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nucleoside analogues for the treatment of coronavirus infections.
    Pruijssers AJ; Denison MR
    Curr Opin Virol; 2019 Apr; 35():57-62. PubMed ID: 31125806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.
    Dyall J; Coleman CM; Hart BJ; Venkataraman T; Holbrook MR; Kindrachuk J; Johnson RF; Olinger GG; Jahrling PB; Laidlaw M; Johansen LM; Lear-Rooney CM; Glass PJ; Hensley LE; Frieman MB
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4885-93. PubMed ID: 24841273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural product-derived phytochemicals as potential agents against coronaviruses: A review.
    Mani JS; Johnson JB; Steel JC; Broszczak DA; Neilsen PM; Walsh KB; Naiker M
    Virus Res; 2020 Jul; 284():197989. PubMed ID: 32360300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The analysis on the human protein domain targets and host-like interacting motifs for the MERS-CoV and SARS-CoV/CoV-2 infers the molecular mimicry of coronavirus.
    Martínez YA; Guo X; Portales-Pérez DP; Rivera G; Castañeda-Delgado JE; García-Pérez CA; Enciso-Moreno JA; Lara-Ramírez EE
    PLoS One; 2021; 16(2):e0246901. PubMed ID: 33596252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.